Better Bone Health
Pioneering Solutions to Understand, Diagnose,
and Treat Bone Conditions
Pioneering
Solutions to Understand, Diagnose,
and Treat
Bone Conditions
Who We Are
Welcome to CompagOs – A leader in the field of human 3D in vitro bone models, paving the way for innovative solutions in bone health. We are on a mission to revolutionize drug development, personalized medicine and regenerative treatments in the domain of bone health.
Discover our services on our Bon3OID™ in vitro models, crafted from human cells. These models serve as a robust foundation for researchers, propelling drug development.
Future Plans
Utilizing our Bon3OID™ technology, we aim to develop blood-based in vitro diagnostic tools for the early detection of bone diseases such as bone metastasis and osteoporosis, while also advancing regenerative medicine solutions to recreate a patient’s bone tissue in severe cancerous and traumatic conditions.
Who We Are
Welcome to CompagOs – A leader in the field of human 3D in vitro bone models, paving the way for innovative solutions in bone health. We are on a mission to revolutionize drug development, personalized medicine and regenerative treatments in the domain of bone health.
Discover our services on our Bon3OID™ in vitro models, crafted from human cells. These models serve as a robust foundation for researchers, propelling drug development.
Future Plans
Utilizing our Bon3OID™ technology, we aim to develop blood-based in vitro diagnostic tools for the early detection of bone diseases such as bone metastasis and osteoporosis, while also advancing regenerative medicine solutions to recreate a patient’s bone tissue in severe cancerous and traumatic conditions.
01 From Cells to Organotypic Bone Models
We use 3D bioprinting to create human mesenchymal stem cell-laden hydrogel scaffolds, either from diseased or healthy donors.
02 Biomechanical Stimulation
These scaffolds are subjected to cyclic mechanical loading, stimulating cell-mediated mineralization and effectively mimicking human biology. Our bioreactors provide precise stimulation, similar to the mechanical load exerted to cells in bones during everyday activities like walking.
03 Introducing Cells
Initially, our organotypic bone models consist of osteoblasts and osteocytes. Depending on specific research and clinical needs, we can introduce other types of cells, including osteoclasts and cancer cells.
How We Make a Difference
Focusing on fields with a high unmet need for better treatments, like osteogenesis imperfecta, osteosarcoma and bone metastases.
Our Supporters
Resources
Check out our latest publications, posters and more.
Brochure
News
Stay updated with our latest news.
October 1, 2024
News
September 12, 2024
News
News
Upcoming Events
Together, at CompagOs, we are creating a healthier future with transformative solutions for bone health. Join us on this exciting journey.
November 21, 2024
Zürich, CH
November 06, 2024
Zeist, NL
Blog
Follow our blog for various topics in the bone domain.
